| Figure 1‑1: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (1 of 5) |
| Figure 1‑2: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (2 of 5) |
| Figure 1‑3: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (3 of 5) |
| Figure 1‑4: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (4 of 5) |
| Figure 1‑5: Cardiac Surgery Device Market Share Ranking by Segment, Global, 2023 (5 of 5) |
| Figure 1‑6: Companies Researched in This Report (1 of 2) |
| Figure 1‑7: Companies Researched in This Report (2 of 2) |
| Figure 1‑8: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (1 of 5) |
| Figure 1‑9: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (2 of 5) |
| Figure 1‑10: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (3 of 5) |
| Figure 1‑11: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (4 of 5) |
| Figure 1‑12: Factors Impacting the Cardiac Surgery Device Market by Segment, Global (5 of 5) |
| Figure 1‑13: Recent Events in the Cardiac Surgery Device Market, Global, 2020 – 2024 (1 of 2) |
| Figure 1‑14: Recent Events in the Cardiac Surgery Device Market, Global, 2020 – 2024 (2 of 2) |
| Figure 1‑15: Cardiac Surgery Device Procedures Covered (1 of 2) |
| Figure 1‑16: Cardiac Surgery Device Procedures Covered (2 of 2) |
| Figure 1‑17: Cardiac Surgery Device Markets Covered (1 of 2) |
| Figure 1‑18: Cardiac Surgery Device Markets Covered (2 of 2) |
| Figure 1‑19: Cardiac Surgery Device Regions Covered, Global (1 of 2) |
| Figure 1‑20: Cardiac Surgery Device Regions Covered, Global (2 of 2) |
| Figure 1‑21: Key Report Updates |
| Figure 1‑22: Version History |
| Figure 2‑1: Cardiac Surgery Device Market by Segment, Worst Case Scenario, Global, 2020 – 2030 (US$M) (1 of 3) |
| Figure 2‑2: Cardiac Surgery Device Market by Segment, Worst Case Scenario, Global, 2020 – 2030 (US$M) (2 of 3) |
| Figure 2‑3: Cardiac Surgery Device Market by Segment, Worst Case Scenario, Global, 2020 – 2030 (US$M) (3 of 3) |
| Figure 2‑4: Cardiac Surgery Device Market by Segment, Base Case Scenario, Global, 2020 – 2030 (US$M) (1 of 3) |
| Figure 2‑5: Cardiac Surgery Device Market by Segment, Base Case Scenario, Global, 2020 – 2030 (US$M) (2 of 3) |
| Figure 2‑6: Cardiac Surgery Device Market by Segment, Base Case Scenario, Global, 2020 – 2030 (US$M) (3 of 3) |
| Figure 2‑7: Cardiac Surgery Device Market by Segment, Best Case Scenario, Global, 2020 – 2030 (US$M) (1 of 3) |
| Figure 2‑8: Cardiac Surgery Device Market by Segment, Best Case Scenario, Global, 2020 – 2030 (US$M) (2 of 3) |
| Figure 2‑9: Cardiac Surgery Device Market by Segment, Best Case Scenario, Global, 2020 – 2030 (US$M) (3 of 3) |
| Figure 4‑1: Tissue Heart Valve Devices by Company |
| Figure 4‑2: Mechanical Heart Valve Devices by Company |
| Figure 4‑3: Annuloplasty Repair Devices by Company |
| Figure 4‑4: Transcatheter Mitral Valve Repair Devices by Company |
| Figure 4‑5: Transcatheter Heart Valve Replacement Devices by Company |
| Figure 4‑6: Cerebral Embolic Protection Devices by Company |
| Figure 4‑7: Balloon Valvuloplasty Devices by Company |
| Figure 4‑8: On-Pump Coronary Artery Bypass Devices by Company (1 of 2) |
| Figure 4‑9: On-Pump Coronary Artery Bypass Devices by Company (2 of 2) |
| Figure 4‑10: Off-Pump Coronary Artery Bypass Devices by Company (1 of 2) |
| Figure 4‑11: Off-Pump Coronary Artery Bypass Devices by Company (2 of 2) |
| Figure 4‑12: Autotransfusion Devices by Company |
| Figure 4‑13: Endoscopic Vessel Harvesting Devices by Company |
| Figure 4‑14: Anastomosis Assist Devices by Company |
| Figure 4‑15: Ventricular Assist Devices by Company |
| Figure 4‑16: Intra-Aortic Balloon Devices by Company |
| Figure 4‑17: Artificial Heart Replacement Devices by Company |
| Figure 4‑18: Patent Foramen Ovale Devices by Company |
| Figure 4‑19: Patent Ductus Arteriosus Closure Devices by Company |
| Figure 4‑20: Atrial & Ventricular Septal Defect Devices by Company |
| Figure 4‑21: Left Atrial Appendage Closure Devices by Company |
| Figure 4‑22: Preshaped Guidewires by Company |
| Figure 4‑23: Transmyocardial Revascularization Devices by Company |
| Figure 4‑24: Extracorporeal Membrane Oxygenation by Company (1 of 2) |
| Figure 4‑25: ECMO by Company (2 of 2) |
| Figure 4‑26: Class 2 Device Recall CryoValve SG Pulmonary Human Heart Valve |
| Figure 4‑27: Class 2 Device Recall PERCEVAL SUTURELESS HEART VALVE |
| Figure 4‑28: Class 2 Device Recall Hancock II T510 Bioprosthesis |
| Figure 4‑29: Class 2 Device Recall Mosaic 310 Bioprosthesis |
| Figure 4‑30: Class 2 Device Recall Cryovalve(R) SG Pulmonary Human Heart Valve |
| Figure 4‑31: Class 2 Device Recall, CryoLife |
| Figure 4‑32: Class 2 Device Recall Medtronic Open Pivot Aortic Valve Graft |
| Figure 4‑33: Class 2 Device Recall OnX Aortic Heart Valve |
| Figure 4‑34: Class 1 Device Recall, CryoLife |
| Figure 4‑35: Class 2 Device Recall Medtronic Simulus 850 Semi Rigid Ring/Band Accessory Kit |
| Figure 4‑36: Class 2 Device Recall Medtronic Simulus 750 Flexible Ring/Band Accessory Kit |
| Figure 4‑37: Class 2 Device Recall MitraClip" and TriClip" Delivery System(s) |
| Figure 4‑38: Class 2 Device Recall Abbott MitraClip XTR Clip Delivery System |
| Figure 4‑39: Class 2 Device Recall, Abbott |
| Figure 4‑40: Class 1 Device Recall Harmony Delivery Catheter System |
| Figure 4‑41: Class 1 Device Recall Lotus Edge Valve System |
| Figure 4‑42: Class 1 Device Recall Edwards Sapien 3 Ultra Delivery System |
| Figure 4‑43: Class 2 Device Recall Edwards SAPIEN 3 Transcatheter Heart Valve (THV) |
| Figure 4‑44: Class 2 Device Recall Quadroxi Pediatric |
| Figure 4‑45: Class 2 Device Recall QUADROXi Small Adult |
| Figure 4‑46: Class 2 Device Recall QUADROX i Neonatal |
| Figure 4‑47: Class 2 Device Recall QUADROXi Small Adult, BIOLINE Coated |
| Figure 4‑48: Class 2 Device Recall QUADROX iR |
| Figure 4‑49: Class 2 Device Recall Quadroxi Adult |
| Figure 4‑50: Class 2 Device Recall QUADROXi Small |
| Figure 4‑51: Class 2 Device Recall CAPIOX NX19 |
| Figure 4‑52: Class 2 Device Recall CAPIOX RX15 |
| Figure 4‑53: Class 2 Device Recall CAPIOX FX25 |
| Figure 4‑54: Class 2 Device Recall Affinity Fusion Oxygenator |
| Figure 4‑55: Class 1 Device Recall LifeSPARC Controller |
| Figure 4‑56: Class 1 Device Recall Affinity Pixie Oxygenator and Cardiotomy/Venous Reservoir with Balance Biosurface |
| Figure 4‑57: Class 2 Device Recall Capiox FX25 Advance Oxygenator |
| Figure 4‑58: Class 3 Device Recall ROTAFLOW Centrifugal Pump System |
| Figure 4‑59: Class 2 Device Recall ROTAFLOW Centrifugal Pump System |
| Figure 4‑60: Class 2 Device Recall Maquet/Getinge |
| Figure 4‑61: Class 3 Device Recall Smart Perfusion Pack |
| Figure 4‑62: Class 2 Device Recall Terumo Capiox NX19 Oxygenator |
| Figure 4‑63: Class 2 Device Recall |
| Figure 4‑64: Class 2 Device Recall ACROBAT V |
| Figure 4‑65: Class 2 Device Recall ACROBAT SUV |
| Figure 4‑66: Class 2 Device Recall ACROBATi |
| Figure 4‑67: Class 2 Device Recall CS Elite Fastpack |
| Figure 4‑68: Class 2 Device Recall CS Elite |
| Figure 4‑69: Class 2 Device Recall CS5/5 Fastpacks |
| Figure 4‑70: Class 2 Device Recall Cell Saver |
| Figure 4‑71: Class 2 Device Recall High Speed Cell Saver |
| Figure 4‑72: Class 2 Device Recall CSE Set |
| Figure 4‑73: Class 2 Device Recall CATSmart Autotransfusion |
| Figure 4‑74: Class 2 Device Recall CATSmart Vacuum Pump |
| Figure 4‑75: Class 2 Device Recall VASOVIEW HEMOPRO |
| Figure 4‑76: Class 2 Device Recall VASOVIEW HEMOPRO 2 |
| Figure 4‑77: Class 2 Device Recall Cardica CPort xA PLUS Anastomosis System |
| Figure 4‑78: Class 2 Device Recall HeartWare" Ventricular Assist Device (HVAD") System |
| Figure 4‑79: Class 1 Device Recall Impella RP Flex with SmartAssist |
| Figure 4‑80: Class 1 Device Recall Impella LD |
| Figure 4‑81: Class 1 Device Recall Impella CP with SmartAssist |
| Figure 4‑82: Class 1 Device Recall Impella 5.0 |
| Figure 4‑83: Class 1 Device Recall Impella 2.5 |
| Figure 4‑84: Class 1 Device Recall Impella CP |
| Figure 4‑85: Class 2 Device Recall HeartWare |
| Figure 4‑86: Class 1 Device Recall Heartware HVAD |
| Figure 4‑87: Class 1 Device Recall HeartWare HVAD Pump Implant Kit |
| Figure 4‑88: Class 2 Device Recall HeartWare Ventricular Assist Device (HVAD) System |
| Figure 4‑89: Class 2 Device Recall HeartWare HVAD System |
| Figure 4‑90: Class 2 Device Recall HeartMate Touch Communication System |
| Figure 4‑91: Class 2 Device Recall TandemHeart Pump |
| Figure 4‑92: Class 1 Device Recall HVAD Pump Implant Kit |
| Figure 4‑93: Class 1 Device Recall HVAD Pump Outflow Graft |
| Figure 4‑94: Class 2 Device Recall HeartMate 3 Left Ventricular Assist System |
| Figure 4‑95: Class 2 Device Recall HeartMate Left Ventricular Assist System |
| Figure 4‑96: Class 2 Device Recall HeartMate Outflow Graft |
| Figure 4‑97: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP) |
| Figure 4‑98: Class 1 Device Recall Cardiosave Rescue IntraAortic Balloon Pump (IABP) |
| Figure 4‑99: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP) |
| Figure 4‑100: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP) |
| Figure 4‑101: Class 2 Device Recall Cardiosave Rescue |
| Figure 4‑102: Class 2 Device Recall Safety Disk |
| Figure 4‑103: Class 2 Device Recall Cardiosave Rescue |
| Figure 4‑104: Class 2 Device Recall Cardiosave Hybrid |
| Figure 4‑105: Class 1 Device Recall Cardiosave Hybrid IntraAortic Balloon Pump (IABP) |
| Figure 4‑106: Class 1 Device Recall Arrow AutoCAT2 |
| Figure 4‑107: Class 1 Device Recall Arrow AC3 Optimus |
| Figure 4‑108: Class 1 Device Recall AutoCAT IABP Series |
| Figure 4‑109: Class 1 Device Recall Arrow AutoCAT2 |
| Figure 4‑110: Class 1 Device Recall AC3 Series IABP System |
| Figure 4‑111: Class 2 Device Recall SynCardia temporary Total Artificial Heart System |
| Figure 4‑112: Class 2 Device Recall Gore Cardioform Septal Occluder |
| Figure 4‑113: Class 2 Device Recall GORE CARDIOFORM SEPTAL OCCLUDER |
| Figure 4‑114: Class 2 Device Recall GORE CARDIOFORM ASD Occluder |
| Figure 4‑115: Class 2 Device Recall Lunderquist Ring Torque Wire Guide |
| Figure 4‑116: Class 1 Device Recall Medtronic Confida Expandable Sheath |
| Figure 4‑117: Class 2 Device Recall HLS Set Advanced |
| Figure 4‑118: Class 2 Device Recall HLS Set Advanced |
| Figure 4‑119: Class 3 Device Recall Cardiac Assist |
| Figure 4‑120: Class 2 Device Recall TandemHeart Pump |
| Figure 4‑121: Class 1 Device Recall CentriMag Acute Circulatory Support System Motor |
| Figure 4‑122: INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study (INVIVITY) |
| Figure 4‑123: Avalus European Registry – an Observational Study to Evaluate Safety and Efficacy in a Real World Population |
| Figure 4‑124: PERCEVAL S Valve Clinical Study for Chinese Registration (PERFECT) |
| Figure 4‑125: INSPIRIS RESILIA Valve in Pulmonary Position |
| Figure 4‑126: Trifecta and Epic ViV Detailed Insights into Management Strategies and Outcomes |
| Figure 4‑127: Trifecta™ Long Term Follow-Up (LTFU) Study |
| Figure 4‑128: Post Market Clinical Follow-Up Study in Patients Treated with the On-X Ascending Aortic Prosthesis (AAP) (ASCEND) |
| Figure 4‑129: Regent China Post-Market Clinical Follow-up Study |
| Figure 4‑130: SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy |
| Figure 4‑131: Retrospective Clinical Data Collection on Carbomedics OptiForm Mitral Heart Valve |
| Figure 4‑132: HALO: A Single Arm Prospective Investigation of the SJM™ Masters HP™ 15mm Rotatable Mechanical Heart Valve |
| Figure 4‑133: On-X Heart Valve - 17mm Aortic and 23mm Mitral |
| Figure 4‑134: HAART Annuloplasty Device Valve Repair Registry |
| Figure 4‑135: Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study (ARB-PMCF) |
| Figure 4‑136: A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients with Functional Mitral Regurgitation |
| Figure 4‑137: Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty with 3D Shaped Rings |
| Figure 4‑138: PRESERVE-MITRAL Post-Market Registry |
| Figure 4‑139: Transcatheter Mitral Valve InterventiOn Single Center Registry in CHinese Patients with Mitral Valve Disease |
| Figure 4‑140: Valveclip® Transcatheter Mitral Valve Repair Study |
| Figure 4‑141: Caisson Transcatheter Mitral Valve Replacement (TMVR) (INTERLUDE) |
| Figure 4‑142: Multicentre Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients with Severe Primary Mitral Regurgitation Eligible for High-risk Surgery (MITRA-HR) |
| Figure 4‑143: Mi-thos® Transcatheter Mitral Valve Replacement (First-in-Man Study) |
| Figure 4‑144: MitraClip for the Treatment of Moderate Functional Mitral Regurgitation: EVOLVE-MR (EVOLVE-MR) |
| Figure 4‑145: The MitraClip® EXPAND Study of the Next Generation of MitraClip® Devices |
| Figure 4‑146: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population (China XT) |
| Figure 4‑147: The PROTEMBO Trial |
| Figure 4‑148: PROTECT TAVI – Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection with the Sentinel™ Device |
| Figure 4‑149: Transcatheter Aortic Valve Replacement (TAVR) Double Balloon Valvuloplasty |
| Figure 4‑150: Mini-invasive Balloon Aortic Valvuloplasty |
| Figure 4‑151: Comparison of Saphenous Vein Harvesting by Endoscopic Versus Open Conventional Methods |
| Figure 4‑152: LVAD Conditioning for Cardiac Recovery |
| Figure 4‑153: EXCOR Active Driving System for the EXCOR Pediatric VAD IDE Study |
| Figure 4‑154: Effect of Cardiac Resynchronization Therapy (CRT) on Left Ventricular Assist Device (LVAD) Function |
| Figure 4‑155: The Left Ventricular Assist Device (LVAD) Off or On Pump Implantation Study |
| Figure 4‑156: A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System |
| Figure 4‑157: Outcome of Patients Treated with IABP |
| Figure 4‑158: Intra-Aortic Balloon Pump in Extensive Myocardial Infarction with Persistent Ischemia |
| Figure 4‑159: Carmat Total Artificial Heart as a Bridge to Transplant in Patients with Advanced Heart Failure |
| Figure 4‑160: SynCardia 70cc TAH-t for Destination Therapy |
| Figure 4‑161: Syncardia 50cc TAH-t as a Bridge to Transplant |
| Figure 4‑162: AMPLATZER PFO Occluder Post Approval Study |
| Figure 4‑163: GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study |
| Figure 4‑164: GORE® CARDIOFORM Septal Occluder Migraine Clinical Study |
| Figure 4‑165: Evaluation of the Efficacy and Safety of a Simplified Procedure for the Percutaneous Closure of the Patent Foramen Ovale |
| Figure 4‑166: Amplatzer PFO Occluder Post-marketing Surveillance Study |
| Figure 4‑167: Internal Microstructure of Patent Foramen Ovale Related to Stroke |
| Figure 4‑168: Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes |
| Figure 4‑169: Amplatzer Piccolo Occluder Japan Post-Marketing Database Surveillance |
| Figure 4‑170: Nit-Occlud PDA Post-Approval Study |
| Figure 4‑171: Procedural Outcomes of Percutaneous PDA Closure: Comparative Study between Different Devices |
| Figure 4‑172: A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography |
| Figure 4‑173: The ICE WATCHMAN Trial |
| Figure 4‑174: VClip Post-Market Study |
| Figure 4‑175: Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong |
| Figure 4‑176: AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures |
| Figure 4‑177: CardioGenesis Transmyocardial Revascularization 1-Year Follow-Up Study |
| Figure 4‑178: CentriMag Failure-to-Wean Post Approval Study |
| Figure 4‑179: Quality of Life 1y and 2 y After VV-ECMO for COVID-19 |
| Figure 4‑180: ECMO Treatment of Children in China in the Past 10 Years |
| Figure 4‑181: TandemHeart Experiences and MEthods |
| Figure 5‑1: Cardiac Surgery Device Market by Segment, Global, 2020 – 2030 (US$M) (1 of 3) |
| Figure 5‑2: Cardiac Surgery Device Market by Segment, Global, 2020 – 2030 (US$M) (2 of 3) |
| Figure 5‑3: Cardiac Surgery Device Market by Segment, Global, 2020 – 2030 (US$M) (3 of 3) |
| Figure 5‑4: Cardiac Surgery Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 5‑5: Leading Competitors, Cardiac Surgery Device Market by Segment, Global, 2023 (1 of 3) |
| Figure 5‑6: Leading Competitors, Cardiac Surgery Device Market by Segment, Global, 2023 (2 of 3) |
| Figure 5‑7: Leading Competitors, Cardiac Surgery Device Market by Segment, Global, 2023 (3 of 3) |
| Figure 5‑8: SWOT Analysis, Abbott (1 of 2) |
| Figure 5‑9: SWOT Analysis, Abbott (2 of 2) |
| Figure 5‑10: SWOT Analysis, Abiomed |
| Figure 5‑11: SWOT Analysis, Artivion |
| Figure 5‑12: SWOT Analysis, AtriCure |
| Figure 5‑13: SWOT Analysis, B. Braun |
| Figure 5‑14: SWOT Analysis, Boston Scientific |
| Figure 5‑15: SWOT Analysis, Edwards Lifesciences |
| Figure 5‑16: SWOT Analysis, Getinge |
| Figure 5‑17: SWOT Analysis, LivaNova |
| Figure 5‑18: SWOT Analysis, Medtronic |
| Figure 5‑19: SWOT Analysis, Terumo |
| Figure 6‑1: Tissue Heart Valve Procedures Covered |
| Figure 6‑2: Tissue Heart Valve Markets Covered |
| Figure 6‑3: Tissue Heart Valve Regions Covered, Global (1 of 2) |
| Figure 6‑4: Tissue Heart Valve Regions Covered, Global (2 of 2) |
| Figure 6‑5: Tissue Heart Valve Procedures by Segment, Global, 2020 – 2030 |
| Figure 6‑6: Tissue Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 6‑7: Tissue Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 6‑8: Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 6‑9: Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 6‑10: Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 6‑11: Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 6‑12: Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 6‑13: Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 6‑14: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 6‑15: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 6‑16: Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 6‑17: Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 6‑18: Aortic Tissue Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 6‑19: Aortic Tissue Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 6‑20: Aortic Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 6‑21: Aortic Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 6‑22: Aortic Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 6‑23: Aortic Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 6‑24: Aortic Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 6‑25: Aortic Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 6‑26: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 6‑27: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 6‑28: Aortic Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 6‑29: Aortic Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 6‑30: Mitral Tissue Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 6‑31: Mitral Tissue Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 6‑32: Mitral Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 6‑33: Mitral Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 6‑34: Mitral Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 6‑35: Mitral Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 6‑36: Mitral Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 6‑37: Mitral Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 6‑38: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 6‑39: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 6‑40: Mitral Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 6‑41: Mitral Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 6‑42: Tricuspid Tissue Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 6‑43: Tricuspid Tissue Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 6‑44: Tricuspid Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 6‑45: Tricuspid Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 6‑46: Tricuspid Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 6‑47: Tricuspid Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 6‑48: Tricuspid Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 6‑49: Tricuspid Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 6‑50: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 6‑51: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 6‑52: Tricuspid Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 6‑53: Tricuspid Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 6‑54: Pulmonary Tissue Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 6‑55: Pulmonary Tissue Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 6‑56: Pulmonary Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 6‑57: Pulmonary Tissue Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 6‑58: Pulmonary Tissue Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 6‑59: Pulmonary Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 6‑60: Pulmonary Tissue Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 6‑61: Pulmonary Tissue Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 6‑62: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 6‑63: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 6‑64: Pulmonary Tissue Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 6‑65: Pulmonary Tissue Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 6‑66: Tissue Heart Valve Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 6‑67: Tissue Heart Valve Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 6‑68: Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑69: Units Sold by Region, Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑70: Average Selling Price by Region, Tissue Heart Valve Market, Global, 2020 – 2030 (US$) |
| Figure 6‑71: Market Value by Region, Tissue Heart Valve Market, Global, 2020 – 2030 (US$M) |
| Figure 6‑72: Stented Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑73: Units Sold by Region, Stented Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑74: Average Selling Price by Region, Stented Tissue Heart Valve Market, Global, 2020 – 2030 (US$) |
| Figure 6‑75: Market Value by Region, Stented Tissue Heart Valve Market, Global, 2020 – 2030 (US$M) |
| Figure 6‑76: Stentless Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑77: Units Sold by Region, Stentless Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑78: Average Selling Price by Region, Stentless Tissue Heart Valve Market, Global, 2020 – 2030 (US$) |
| Figure 6‑79: Market Value by Region, Stentless Tissue Heart Valve Market, Global, 2020 – 2030 (US$M) |
| Figure 6‑80: Sutureless Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑81: Units Sold by Region, Sutureless Tissue Heart Valve Market, Global, 2020 – 2030 |
| Figure 6‑82: Average Selling Price by Region, Sutureless Tissue Heart Valve Market, Global, 2020 – 2030 (US$) |
| Figure 6‑83: Market Value by Region, Sutureless Tissue Heart Valve Market, Global, 2020 – 2030 (US$M) |
| Figure 6‑84: Leading Competitors, Tissue Heart Valve Market, Global, 2023 |
| Figure 7‑1: Mechanical Heart Valve Procedures Covered |
| Figure 7‑2: Mechanical Heart Valve Regions Covered, Global (1 of 2) |
| Figure 7‑3: Mechanical Heart Valve Regions Covered, Global (2 of 2) |
| Figure 7‑4: Mechanical Heart Valve Procedures by Segment, Global, 2020 – 2030 |
| Figure 7‑5: Mechanical Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 7‑6: Mechanical Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 7‑7: Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 7‑8: Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 7‑9: Mechanical Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 7‑10: Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 7‑11: Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 7‑12: Mechanical Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 7‑13: Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 7‑14: Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 7‑15: Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 7‑16: Mechanical Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 7‑17: Aortic Mechanical Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 7‑18: Aortic Mechanical Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 7‑19: Aortic Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 7‑20: Aortic Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 7‑21: Aortic Mechanical Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 7‑22: Aortic Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 7‑23: Aortic Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 7‑24: Aortic Mechanical Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 7‑25: Aortic Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 7‑26: Aortic Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 7‑27: Aortic Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 7‑28: Aortic Mechanical Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 7‑29: Mitral Mechanical Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 7‑30: Mitral Mechanical Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 7‑31: Mitral Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 7‑32: Mitral Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 7‑33: Mitral Mechanical Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 7‑34: Mitral Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 7‑35: Mitral Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 7‑36: Mitral Mechanical Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 7‑37: Mitral Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 7‑38: Mitral Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 7‑39: Mitral Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 7‑40: Mitral Mechanical Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 7‑41: Tricuspid Mechanical Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 7‑42: Tricuspid Mechanical Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 7‑43: Tricuspid Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 7‑44: Tricuspid Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 7‑45: Tricuspid Mechanical Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 7‑46: Tricuspid Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 7‑47: Tricuspid Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 7‑48: Tricuspid Mechanical Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 7‑49: Tricuspid Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 7‑50: Tricuspid Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 7‑51: Tricuspid Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 7‑52: Tricuspid Mechanical Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 7‑53: Pulmonary Mechanical Heart Valve Procedures by Region, Global, 2020 – 2030 |
| Figure 7‑54: Pulmonary Mechanical Heart Valve Procedures by Country, North America, 2020 – 2030 |
| Figure 7‑55: Pulmonary Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 7‑56: Pulmonary Mechanical Heart Valve Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 7‑57: Pulmonary Mechanical Heart Valve Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 7‑58: Pulmonary Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 7‑59: Pulmonary Mechanical Heart Valve Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 7‑60: Pulmonary Mechanical Heart Valve Procedures by Country, Middle East, 2020 – 2030 |
| Figure 7‑61: Pulmonary Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 7‑62: Pulmonary Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 7‑63: Pulmonary Mechanical Heart Valve Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 7‑64: Pulmonary Mechanical Heart Valve Procedures by Country, Africa, 2020 – 2030 |
| Figure 7‑65: Mechanical Heart Valve Market, Global, 2020 – 2030 |
| Figure 7‑66: Units Sold by Region, Mechanical Heart Valve Market, Global, 2020 – 2030 |
| Figure 7‑67: Average Selling Price by Region, Mechanical Heart Valve Market, Global, 2020 – 2030 (US$) |
| Figure 7‑68: Market Value by Region, Mechanical Heart Valve Market, Global, 2020 – 2030 (US$M) |
| Figure 7‑69: Leading Competitors, Mechanical Heart Valve Market, Global, 2023 |
| Figure 8‑1: Annuloplasty Repair Device Procedures Covered |
| Figure 8‑2: Annuloplasty Repair Device Regions Covered, Global (1 of 2) |
| Figure 8‑3: Annuloplasty Repair Device Regions Covered, Global (2 of 2) |
| Figure 8‑4: Annuloplasty Repair Procedures by Segment, Global, 2020 – 2030 |
| Figure 8‑5: Annuloplasty Repair Procedures by Region, Global, 2020 – 2030 |
| Figure 8‑6: Annuloplasty Repair Procedures by Country, North America, 2020 – 2030 |
| Figure 8‑7: Annuloplasty Repair Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 8‑8: Annuloplasty Repair Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 8‑9: Annuloplasty Repair Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 8‑10: Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 8‑11: Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 8‑12: Annuloplasty Repair Procedures by Country, Middle East, 2020 – 2030 |
| Figure 8‑13: Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 8‑14: Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 8‑15: Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 8‑16: Annuloplasty Repair Procedures by Country, Africa, 2020 – 2030 |
| Figure 8‑17: Mitral Annuloplasty Repair Procedures by Region, Global, 2020 – 2030 |
| Figure 8‑18: Mitral Annuloplasty Repair Procedures by Country, North America, 2020 – 2030 |
| Figure 8‑19: Mitral Annuloplasty Repair Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 8‑20: Mitral Annuloplasty Repair Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 8‑21: Mitral Annuloplasty Repair Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 8‑22: Mitral Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 8‑23: Mitral Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 8‑24: Mitral Annuloplasty Repair Procedures by Country, Middle East, 2020 – 2030 |
| Figure 8‑25: Mitral Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 8‑26: Mitral Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 8‑27: Mitral Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 8‑28: Mitral Annuloplasty Repair Procedures by Country, Africa, 2020 – 2030 |
| Figure 8‑29: Tricuspid Annuloplasty Repair Procedures by Region, Global, 2020 – 2030 |
| Figure 8‑30: Tricuspid Annuloplasty Repair Procedures by Country, North America, 2020 – 2030 |
| Figure 8‑31: Tricuspid Annuloplasty Repair Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 8‑32: Tricuspid Annuloplasty Repair Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 8‑33: Tricuspid Annuloplasty Repair Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 8‑34: Tricuspid Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 8‑35: Tricuspid Annuloplasty Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 8‑36: Tricuspid Annuloplasty Repair Procedures by Country, Middle East, 2020 – 2030 |
| Figure 8‑37: Tricuspid Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 8‑38: Tricuspid Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 8‑39: Tricuspid Annuloplasty Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 8‑40: Tricuspid Annuloplasty Repair Procedures by Country, Africa, 2020 – 2030 |
| Figure 8‑41: Annuloplasty Repair Device Market, Global, 2020 – 2030 |
| Figure 8‑42: Units Sold by Region, Annuloplasty Repair Device Market, Global, 2020 – 2030 |
| Figure 8‑43: Average Selling Price by Region, Annuloplasty Repair Device Market, Global, 2020 – 2030 (US$) |
| Figure 8‑44: Market Value by Region, Annuloplasty Repair Device Market, Global, 2020 – 2030 (US$M) |
| Figure 8‑45: Leading Competitors, Annuloplasty Repair Device Market, Global, 2023 |
| Figure 9‑1: Transcatheter Mitral Valve Repair Procedures Covered |
| Figure 9‑2: Transcatheter Mitral Valve Repair Regions Covered, Global (1 of 2) |
| Figure 9‑3: Transcatheter Mitral Valve Repair Regions Covered, Global (2 of 2) |
| Figure 9‑4: Transcatheter Mitral Valve Repair Procedures by Region, Global, 2020 – 2030 |
| Figure 9‑5: Transcatheter Mitral Valve Repair Procedures by Country, North America, 2020 – 2030 |
| Figure 9‑6: Transcatheter Mitral Valve Repair Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 9‑7: Transcatheter Mitral Valve Repair Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 9‑8: Transcatheter Mitral Valve Repair Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 9‑9: Transcatheter Mitral Valve Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 9‑10: Transcatheter Mitral Valve Repair Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 9‑11: Transcatheter Mitral Valve Repair Procedures by Country, Middle East, 2020 – 2030 |
| Figure 9‑12: Transcatheter Mitral Valve Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 9‑13: Transcatheter Mitral Valve Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 9‑14: Transcatheter Mitral Valve Repair Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 9‑15: Transcatheter Mitral Valve Repair Procedures by Country, Africa, 2020 – 2030 |
| Figure 9‑16: Transcatheter Mitral Valve Repair Market, Global, 2020 – 2030 |
| Figure 9‑17: Units Sold by Region, Transcatheter Mitral Valve Repair Market, Global, 2020 – 2030 |
| Figure 9‑18: Average Selling Price by Region, Transcatheter Mitral Valve Repair Market, Global, 2020 – 2030 (US$) |
| Figure 9‑19: Market Value by Region, Transcatheter Mitral Valve Repair Market, Global, 2020 – 2030 (US$M) |
| Figure 9‑20: Leading Competitors, Transcatheter Mitral Valve Repair Market, Global, 2023 |
| Figure 10‑1: Transcatheter Heart Valve Replacement Procedures Covered |
| Figure 10‑2: Transcatheter Heart Valve Replacement Markets Covered |
| Figure 10‑3: Transcatheter Heart Valve Replacement Regions Covered, Global (1 of 2) |
| Figure 10‑4: Transcatheter Heart Valve Replacement Regions Covered, Global (2 of 2) |
| Figure 10‑5: Transcatheter Heart Valve Replacement Procedures by Segment, Global, 2020 – 2030 |
| Figure 10‑6: Transcatheter Heart Valve Replacement Procedures by Region, Global, 2020 – 2030 |
| Figure 10‑7: Transcatheter Heart Valve Replacement Procedures by Country, North America, 2020 – 2030 |
| Figure 10‑8: Transcatheter Heart Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 10‑9: Transcatheter Heart Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 10‑10: Transcatheter Heart Valve Replacement Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 10‑11: Transcatheter Heart Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 10‑12: Transcatheter Heart Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 10‑13: Transcatheter Heart Valve Replacement Procedures by Country, Middle East, 2020 – 2030 |
| Figure 10‑14: Transcatheter Heart Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 10‑15: Transcatheter Heart Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 10‑16: Transcatheter Heart Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 10‑17: Transcatheter Heart Valve Replacement Procedures by Country, Africa, 2020 – 2030 |
| Figure 10‑18: Transcatheter Aortic Valve Replacement Procedures by Protection, Global, 2020 – 2030 |
| Figure 10‑19: Transcatheter Aortic Valve Replacement Procedures by Region, Global, 2020 – 2030 |
| Figure 10‑20: Transcatheter Aortic Valve Replacement Procedures by Country, North America, 2020 – 2030 |
| Figure 10‑21: Transcatheter Aortic Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 10‑22: Transcatheter Aortic Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 10‑23: Transcatheter Aortic Valve Replacement Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 10‑24: Transcatheter Aortic Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 10‑25: Transcatheter Aortic Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 10‑26: Transcatheter Aortic Valve Replacement Procedures by Country, Middle East, 2020 – 2030 |
| Figure 10‑27: Transcatheter Aortic Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 10‑28: Transcatheter Aortic Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 10‑29: Transcatheter Aortic Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 10‑30: Transcatheter Aortic Valve Replacement Procedures by Country, Africa, 2020 – 2030 |
| Figure 10‑31: TAVR with Cerebral Embolic Protection Procedures by Region, Global, 2020 – 2030 |
| Figure 10‑32: TAVR with Cerebral Embolic Protection Procedures by Country, North America, 2020 – 2030 |
| Figure 10‑33: TAVR with Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 10‑34: TAVR with Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 10‑35: TAVR with Cerebral Embolic Protection Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 10‑36: TAVR with Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 10‑37: TAVR with Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 10‑38: TAVR with Cerebral Embolic Protection Procedures by Country, Middle East, 2020 – 2030 |
| Figure 10‑39: TAVR with Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 10‑40: TAVR with Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 10‑41: TAVR with Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 10‑42: TAVR with Cerebral Embolic Protection Procedures by Country, Africa, 2020 – 2030 |
| Figure 10‑43: TAVR without Cerebral Embolic Protection Procedures by Region, Global, 2020 – 2030 |
| Figure 10‑44: TAVR without Cerebral Embolic Protection Procedures by Country, North America, 2020 – 2030 |
| Figure 10‑45: TAVR without Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 10‑46: TAVR without Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 10‑47: TAVR without Cerebral Embolic Protection Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 10‑48: TAVR without Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 10‑49: TAVR without Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 10‑50: TAVR without Cerebral Embolic Protection Procedures by Country, Middle East, 2020 – 2030 |
| Figure 10‑51: TAVR without Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 10‑52: TAVR without Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 10‑53: TAVR without Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 10‑54: TAVR without Cerebral Embolic Protection Procedures by Country, Africa, 2020 – 2030 |
| Figure 10‑55: Transcatheter Pulmonary Valve Replacement Procedures by Region, Global, 2020 – 2030 |
| Figure 10‑56: Transcatheter Pulmonary Valve Replacement Procedures by Country, North America, 2020 – 2030 |
| Figure 10‑57: Transcatheter Pulmonary Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 10‑58: Transcatheter Pulmonary Valve Replacement Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 10‑59: Transcatheter Pulmonary Valve Replacement Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 10‑60: Transcatheter Pulmonary Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 10‑61: Transcatheter Pulmonary Valve Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 10‑62: Transcatheter Pulmonary Valve Replacement Procedures by Country, Middle East, 2020 – 2030 |
| Figure 10‑63: Transcatheter Pulmonary Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 10‑64: Transcatheter Pulmonary Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 10‑65: Transcatheter Pulmonary Valve Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 10‑66: Transcatheter Pulmonary Valve Replacement Procedures by Country, Africa, 2020 – 2030 |
| Figure 10‑67: Transcatheter Heart Valve Replacement Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 10‑68: Transcatheter Heart Valve Replacement Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 10‑69: Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030 |
| Figure 10‑70: Units Sold by Region, Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030 |
| Figure 10‑71: Average Selling Price by Region, Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030 (US$) |
| Figure 10‑72: Market Value by Region, Transcatheter Heart Valve Replacement Market, Global, 2020 – 2030 (US$M) |
| Figure 10‑73: Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030 |
| Figure 10‑74: Units Sold by Region, Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030 |
| Figure 10‑75: Average Selling Price by Region, Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030 (US$) |
| Figure 10‑76: Market Value by Region, Transcatheter Aortic Valve Replacement Market, Global, 2020 – 2030 (US$M) |
| Figure 10‑77: Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030 |
| Figure 10‑78: Units Sold by Region, Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030 |
| Figure 10‑79: Average Selling Price by Region, Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030 (US$) |
| Figure 10‑80: Market Value by Region, Transcatheter Pulmonary Valve Replacement Market, Global, 2020 – 2030 (US$M) |
| Figure 10‑81: Leading Competitors, Transcatheter Heart Valve Replacement Market, Global, 2023 |
| Figure 11‑1: Cerebral Embolic Protection Device Procedures Covered |
| Figure 11‑2: Cerebral Embolic Protection Device Regions Covered, Global (1 of 2) |
| Figure 11‑3: Cerebral Embolic Protection Device Regions Covered, Global (2 of 2) |
| Figure 11‑4: Cerebral Embolic Protection Procedures by Region, Global, 2020 – 2030 |
| Figure 11‑5: Cerebral Embolic Protection Procedures by Country, North America, 2020 – 2030 |
| Figure 11‑6: Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 11‑7: Cerebral Embolic Protection Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 11‑8: Cerebral Embolic Protection Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 11‑9: Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 11‑10: Cerebral Embolic Protection Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 11‑11: Cerebral Embolic Protection Procedures by Country, Middle East, 2020 – 2030 |
| Figure 11‑12: Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 11‑13: Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 11‑14: Cerebral Embolic Protection Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 11‑15: Cerebral Embolic Protection Procedures by Country, Africa, 2020 – 2030 |
| Figure 11‑16: Cerebral Embolic Protection Device Market, Global, 2020 – 2030 |
| Figure 11‑17: Units Sold by Region, Cerebral Embolic Protection Device Market, Global, 2020 – 2030 |
| Figure 11‑18: Average Selling Price by Region, Cerebral Embolic Protection Device Market, Global, 2020 – 2030 (US$) |
| Figure 11‑19: Market Value by Region, Cerebral Embolic Protection Device Market, Global, 2020 – 2030 (US$M) |
| Figure 11‑20: Leading Competitors, Cerebral Embolic Protection Device Market, Global, 2023 |
| Figure 12‑1: Balloon Valvuloplasty Procedures Covered |
| Figure 12‑2: Balloon Valvuloplasty Markets Covered |
| Figure 12‑3: Balloon Valvuloplasty Regions Covered, Global (1 of 2) |
| Figure 12‑4: Balloon Valvuloplasty Regions Covered, Global (2 of 2) |
| Figure 12‑5: Balloon Valvuloplasty Procedures by Segment, Global, 2020 – 2030 |
| Figure 12‑6: Balloon Valvuloplasty Procedures by Region, Global, 2020 – 2030 |
| Figure 12‑7: Balloon Valvuloplasty Procedures by Country, North America, 2020 – 2030 |
| Figure 12‑8: Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 12‑9: Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 12‑10: Balloon Valvuloplasty Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 12‑11: Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 12‑12: Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 12‑13: Balloon Valvuloplasty Procedures by Country, Middle East, 2020 – 2030 |
| Figure 12‑14: Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 12‑15: Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 12‑16: Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 12‑17: Balloon Valvuloplasty Procedures by Country, Africa, 2020 – 2030 |
| Figure 12‑18: Aortic Balloon Valvuloplasty Procedures by Region, Global, 2020 – 2030 |
| Figure 12‑19: Aortic Balloon Valvuloplasty Procedures by Country, North America, 2020 – 2030 |
| Figure 12‑20: Aortic Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 12‑21: Aortic Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 12‑22: Aortic Balloon Valvuloplasty Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 12‑23: Aortic Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 12‑24: Aortic Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 12‑25: Aortic Balloon Valvuloplasty Procedures by Country, Middle East, 2020 – 2030 |
| Figure 12‑26: Aortic Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 12‑27: Aortic Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 12‑28: Aortic Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 12‑29: Aortic Balloon Valvuloplasty Procedures by Country, Africa, 2020 – 2030 |
| Figure 12‑30: Mitral Balloon Valvuloplasty Procedures by Region, Global, 2020 – 2030 |
| Figure 12‑31: Mitral Balloon Valvuloplasty Procedures by Country, North America, 2020 – 2030 |
| Figure 12‑32: Mitral Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 12‑33: Mitral Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 12‑34: Mitral Balloon Valvuloplasty Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 12‑35: Mitral Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 12‑36: Mitral Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 12‑37: Mitral Balloon Valvuloplasty Procedures by Country, Middle East, 2020 – 2030 |
| Figure 12‑38: Mitral Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 12‑39: Mitral Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 12‑40: Mitral Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 12‑41: Mitral Balloon Valvuloplasty Procedures by Country, Africa, 2020 – 2030 |
| Figure 12‑42: Pulmonary Balloon Valvuloplasty Procedures by Region, Global, 2020 – 2030 |
| Figure 12‑43: Pulmonary Balloon Valvuloplasty Procedures by Country, North America, 2020 – 2030 |
| Figure 12‑44: Pulmonary Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 12‑45: Pulmonary Balloon Valvuloplasty Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 12‑46: Pulmonary Balloon Valvuloplasty Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 12‑47: Pulmonary Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 12‑48: Pulmonary Balloon Valvuloplasty Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 12‑49: Pulmonary Balloon Valvuloplasty Procedures by Country, Middle East, 2020 – 2030 |
| Figure 12‑50: Pulmonary Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 12‑51: Pulmonary Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 12‑52: Pulmonary Balloon Valvuloplasty Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 12‑53: Pulmonary Balloon Valvuloplasty Procedures by Country, Africa, 2020 – 2030 |
| Figure 12‑54: Balloon Valvuloplasty Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 12‑55: Balloon Valvuloplasty Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 12‑56: Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑57: Units Sold by Region, Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑58: Average Selling Price by Region, Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$) |
| Figure 12‑59: Market Value by Region, Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$M) |
| Figure 12‑60: Aortic Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑61: Units Sold by Region, Aortic Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑62: Average Selling Price by Region, Aortic Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$) |
| Figure 12‑63: Market Value by Region, Aortic Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$M) |
| Figure 12‑64: Mitral Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑65: Units Sold by Region, Mitral Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑66: Average Selling Price by Region, Mitral Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$) |
| Figure 12‑67: Market Value by Region, Mitral Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$M) |
| Figure 12‑68: Pulmonary Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑69: Units Sold by Region, Pulmonary Balloon Valvuloplasty Market, Global, 2020 – 2030 |
| Figure 12‑70: Average Selling Price by Region, Pulmonary Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$) |
| Figure 12‑71: Market Value by Region, Pulmonary Balloon Valvuloplasty Market, Global, 2020 – 2030 (US$M) |
| Figure 12‑72: Leading Competitors, Balloon Valvuloplasty Market, Global, 2023 |
| Figure 13‑1: On-Pump Coronary Artery Bypass Device Procedures Covered |
| Figure 13‑2: On-Pump Coronary Artery Bypass Device Markets Covered |
| Figure 13‑3: On-Pump Coronary Artery Bypass Device Regions Covered, Global (1 of 2) |
| Figure 13‑4: On-Pump Coronary Artery Bypass Device Regions Covered, Global (2 of 2) |
| Figure 13‑5: Coronary Artery Bypass Grafting Procedures by Support Type, Global, 2020 – 2030 |
| Figure 13‑6: Coronary Artery Bypass Grafting Procedures by Region, Global, 2020 – 2030 |
| Figure 13‑7: Coronary Artery Bypass Grafting Procedures by Country, North America, 2020 – 2030 |
| Figure 13‑8: Coronary Artery Bypass Grafting Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 13‑9: Coronary Artery Bypass Grafting Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 13‑10: Coronary Artery Bypass Grafting Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 13‑11: Coronary Artery Bypass Grafting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 13‑12: Coronary Artery Bypass Grafting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 13‑13: Coronary Artery Bypass Grafting Procedures by Country, Middle East, 2020 – 2030 |
| Figure 13‑14: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 13‑15: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 13‑16: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 13‑17: Coronary Artery Bypass Grafting Procedures by Country, Africa, 2020 – 2030 |
| Figure 13‑18: On-Pump Coronary Artery Bypass CABG Procedures by Region, Global, 2020 – 2030 |
| Figure 13‑19: On-Pump Coronary Artery Bypass CABG Procedures by Country, North America, 2020 – 2030 |
| Figure 13‑20: On-Pump Coronary Artery Bypass CABG Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 13‑21: On-Pump Coronary Artery Bypass CABG Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 13‑22: On-Pump Coronary Artery Bypass CABG Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 13‑23: On-Pump Coronary Artery Bypass CABG Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 13‑24: On-Pump Coronary Artery Bypass CABG Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 13‑25: On-Pump Coronary Artery Bypass CABG Procedures by Country, Middle East, 2020 – 2030 |
| Figure 13‑26: On-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 13‑27: On-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 13‑28: On-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 13‑29: On-Pump Coronary Artery Bypass CABG Procedures by Country, Africa, 2020 – 2030 |
| Figure 13‑30: On-Pump Coronary Artery Bypass Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 13‑31: On-Pump Coronary Artery Bypass Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 13‑32: ONCAB Disposables Market, Global, 2020 – 2030 |
| Figure 13‑33: Units Sold by Region, ONCAB Disposables Market, Global, 2020 – 2030 |
| Figure 13‑34: Average Selling Price by Region, ONCAB Disposables Market, Global, 2020 – 2030 (US$) |
| Figure 13‑35: Market Value by Region, ONCAB Disposables Market, Global, 2020 – 2030 (US$M) |
| Figure 13‑36: Perfusion System Market, Global, 2020 – 2030 |
| Figure 13‑37: Units Sold by Region, Perfusion System Market, Global, 2020 – 2030 |
| Figure 13‑38: Average Selling Price by Region, Perfusion System Market, Global, 2020 – 2030 (US$) |
| Figure 13‑39: Market Value by Region, Perfusion System Market, Global, 2020 – 2030 (US$M) |
| Figure 13‑40: Installed Base by Region, Perfusion System Market, Global, 2020 – 2030 |
| Figure 13‑41: Leading Competitors, On-Pump Coronary Artery Bypass Device Market, Global, 2023 |
| Figure 14‑1: Off-Pump Coronary Artery Bypass Device Procedures Covered |
| Figure 14‑2: Off-Pump Coronary Artery Bypass Device Markets Covered |
| Figure 14‑3: Off-Pump Coronary Artery Bypass Device Regions Covered, Global (1 of 2) |
| Figure 14‑4: Off-Pump Coronary Artery Bypass Device Regions Covered, Global (2 of 2) |
| Figure 14‑5: Coronary Artery Bypass Grafting Procedures by Support Type, Global, 2020 – 2030 |
| Figure 14‑6: Coronary Artery Bypass Grafting Procedures by Region, Global, 2020 – 2030 |
| Figure 14‑7: Coronary Artery Bypass Grafting Procedures by Country, North America, 2020 – 2030 |
| Figure 14‑8: Coronary Artery Bypass Grafting Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 14‑9: Coronary Artery Bypass Grafting Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 14‑10: Coronary Artery Bypass Grafting Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 14‑11: Coronary Artery Bypass Grafting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 14‑12: Coronary Artery Bypass Grafting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 14‑13: Coronary Artery Bypass Grafting Procedures by Country, Middle East, 2020 – 2030 |
| Figure 14‑14: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 14‑15: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 14‑16: Coronary Artery Bypass Grafting Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 14‑17: Coronary Artery Bypass Grafting Procedures by Country, Africa, 2020 – 2030 |
| Figure 14‑18: Off-Pump Coronary Artery Bypass CABG Procedures by Region, Global, 2020 – 2030 |
| Figure 14‑19: Off-Pump Coronary Artery Bypass CABG Procedures by Country, North America, 2020 – 2030 |
| Figure 14‑20: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 14‑21: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 14‑22: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 14‑23: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 14‑24: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 14‑25: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Middle East, 2020 – 2030 |
| Figure 14‑26: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 14‑27: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 14‑28: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 14‑29: Off-Pump Coronary Artery Bypass CABG Procedures by Country, Africa, 2020 – 2030 |
| Figure 14‑30: Off-Pump Coronary Artery Bypass Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 14‑31: Off-Pump Coronary Artery Bypass Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 14‑32: Off-Pump Coronary Artery Bypass Device Market, Global, 2020 – 2030 |
| Figure 14‑33: Units Sold by Region, Off-Pump Coronary Artery Bypass Device Market, Global, 2020 – 2030 |
| Figure 14‑34: Average Selling Price by Region, Off-Pump Coronary Artery Bypass Device Market, Global, 2020 – 2030 (US$) |
| Figure 14‑35: Market Value by Region, Off-Pump Coronary Artery Bypass Device Market, Global, 2020 – 2030 (US$M) |
| Figure 14‑36: Stabilizer Device Market, Global, 2020 – 2030 |
| Figure 14‑37: Units Sold by Region, Stabilizer Device Market, Global, 2020 – 2030 |
| Figure 14‑38: Average Selling Price by Region, Stabilizer Device Market, Global, 2020 – 2030 (US$) |
| Figure 14‑39: Market Value by Region, Stabilizer Device Market, Global, 2020 – 2030 (US$M) |
| Figure 14‑40: Positioner Market, Global, 2020 – 2030 |
| Figure 14‑41: Units Sold by Region, Positioner Market, Global, 2020 – 2030 |
| Figure 14‑42: Average Selling Price by Region, Positioner Market, Global, 2020 – 2030 (US$) |
| Figure 14‑43: Market Value by Region, Positioner Market, Global, 2020 – 2030 (US$M) |
| Figure 14‑44: Leading Competitors, Off-Pump Coronary Artery Bypass Device Market, Global, 2023 |
| Figure 15‑1: Autotransfusion Device Procedures Covered |
| Figure 15‑2: Autotransfusion Device Markets Covered |
| Figure 15‑3: Autotransfusion Device Regions Covered, Global (1 of 2) |
| Figure 15‑4: Autotransfusion Device Regions Covered, Global (2 of 2) |
| Figure 15‑5: Autotransfusion Procedures by Region, Global, 2020 – 2030 |
| Figure 15‑6: Autotransfusion Procedures by Country, North America, 2020 – 2030 |
| Figure 15‑7: Autotransfusion Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 15‑8: Autotransfusion Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 15‑9: Autotransfusion Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 15‑10: Autotransfusion Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 15‑11: Autotransfusion Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 15‑12: Autotransfusion Procedures by Country, Middle East, 2020 – 2030 |
| Figure 15‑13: Autotransfusion Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 15‑14: Autotransfusion Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 15‑15: Autotransfusion Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 15‑16: Autotransfusion Procedures by Country, Africa, 2020 – 2030 |
| Figure 15‑17: Autotransfusion Device Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 15‑18: Autotransfusion Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 15‑19: Autotransfusion Machines Market, Global, 2020 – 2030 |
| Figure 15‑20: Units Sold by Region, Autotransfusion Machines Market, Global, 2020 – 2030 |
| Figure 15‑21: Average Selling Price by Region, Autotransfusion Machines Market, Global, 2020 – 2030 (US$) |
| Figure 15‑22: Market Value by Region, Autotransfusion Machines Market, Global, 2020 – 2030 (US$M) |
| Figure 15‑23: Installed Base by Region, Autotransfusion Machines Market, Global, 2020 – 2030 |
| Figure 15‑24: Autotransfusion Disposables Market, Global, 2020 – 2030 |
| Figure 15‑25: Units Sold by Region, Autotransfusion Disposables Market, Global, 2020 – 2030 |
| Figure 15‑26: Average Selling Price by Region, Autotransfusion Disposables Market, Global, 2020 – 2030 (US$) |
| Figure 15‑27: Market Value by Region, Autotransfusion Disposables Market, Global, 2020 – 2030 (US$M) |
| Figure 15‑28: Leading Competitors, Autotransfusion Device Market, Global, 2023 |
| Figure 16‑1: Endoscopic Vessel Harvesting Device Procedures Covered |
| Figure 16‑2: Endoscopic Vessel Harvesting Device Regions Covered, Global (1 of 2) |
| Figure 16‑3: Endoscopic Vessel Harvesting Device Regions Covered, Global (2 of 2) |
| Figure 16‑4: Endoscopic Vessel Harvesting Device Procedures by Region, Global, 2020 – 2030 |
| Figure 16‑5: CABG Procedures by Region, Global, 2020 – 2030 |
| Figure 16‑6: Endoscopic Vessel Harvesting Procedures by Country, North America, 2020 – 2030 |
| Figure 16‑7: Endoscopic Vessel Harvesting Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 16‑8: Endoscopic Vessel Harvesting Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 16‑9: Endoscopic Vessel Harvesting Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 16‑10: Endoscopic Vessel Harvesting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 16‑11: Endoscopic Vessel Harvesting Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 16‑12: Endoscopic Vessel Harvesting Procedures by Country, Middle East, 2020 – 2030 |
| Figure 16‑13: Endoscopic Vessel Harvesting Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 16‑14: Endoscopic Vessel Harvesting Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 16‑15: Endoscopic Vessel Harvesting Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 16‑16: Endoscopic Vessel Harvesting Procedures by Country, Africa, 2020 – 2030 |
| Figure 16‑17: Endoscopic Vessel Harvesting Device Market, Global, 2020 – 2030 |
| Figure 16‑18: Units Sold by Region, Endoscopic Vessel Harvesting Device Market, Global, 2020 – 2030 |
| Figure 16‑19: Average Selling Price by Region, Endoscopic Vessel Harvesting Device Market, Global, 2020 – 2030 (US$) |
| Figure 16‑20: Market Value by Region, Endoscopic Vessel Harvesting Device Market, Global, 2020 – 2030 (US$M) |
| Figure 16‑21: Leading Competitors, Endoscopic Vessel Harvesting Device Market, Global, 2023 |
| Figure 17‑1: Anastomosis Assist Device Procedures Covered |
| Figure 17‑2: Anastomosis Assist Device Regions Covered, Global (1 of 2) |
| Figure 17‑3: Anastomosis Assist Device Regions Covered, Global (2 of 2) |
| Figure 17‑4: Anastomosis Assist Device Procedures by Region, Global, 2020 – 2030 |
| Figure 17‑5: Total CABG Procedures by Region, Global, 2020 – 2030 |
| Figure 17‑6: Anastomosis Assist Device Procedures by Country, North America, 2020 – 2030 |
| Figure 17‑7: Anastomosis Assist Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 17‑8: Anastomosis Assist Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 17‑9: Anastomosis Assist Device Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 17‑10: Anastomosis Assist Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 17‑11: Anastomosis Assist Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 17‑12: Anastomosis Assist Device Procedures by Country, Middle East, 2020 – 2030 |
| Figure 17‑13: Anastomosis Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 17‑14: Anastomosis Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 17‑15: Anastomosis Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 17‑16: Anastomosis Assist Device Procedures by Country, Africa, 2020 – 2030 |
| Figure 17‑17: Anastomosis Assist Device Market, Global, 2020 – 2030 |
| Figure 17‑18: Units Sold by Region, Anastomosis Assist Device Market, Global, 2020 – 2030 |
| Figure 17‑19: Average Selling Price by Region, Anastomosis Assist Device Market, Global, 2020 – 2030 (US$) |
| Figure 17‑20: Market Value by Region, Anastomosis Assist Device Market, Global, 2020 – 2030 (US$M) |
| Figure 17‑21: Leading Competitors, Anastomosis Assist Device Market, Global, 2023 |
| Figure 18‑1: Ventricular Assist Device Procedures Covered |
| Figure 18‑2: Ventricular Assist Device Markets Covered |
| Figure 18‑3: Ventricular Assist Device Regions Covered, Global (1 of 2) |
| Figure 18‑4: Ventricular Assist Device Regions Covered, Global (2 of 2) |
| Figure 18‑5: Total Ventricular Assist Device Procedures by Type, Global, 2020 – 2030 |
| Figure 18‑6: Ventricular Assist Device Procedures by Region, Global, 2020 – 2030 |
| Figure 18‑7: Ventricular Assist Device Procedures by Country, North America, 2020 – 2030 |
| Figure 18‑8: Ventricular Assist Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 18‑9: Ventricular Assist Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 18‑10: Ventricular Assist Device Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 18‑11: Ventricular Assist Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 18‑12: Ventricular Assist Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 18‑13: Ventricular Assist Device Procedures by Country, Middle East, 2020 – 2030 |
| Figure 18‑14: Ventricular Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 18‑15: Ventricular Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 18‑16: Ventricular Assist Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 18‑17: Ventricular Assist Device Procedures by Country, Africa, 2020 – 2030 |
| Figure 18‑18: Percutaneous VAD Procedures by Region, Global, 2020 – 2030 |
| Figure 18‑19: Percutaneous VAD Procedures by Country, North America, 2020 – 2030 |
| Figure 18‑20: Percutaneous VAD Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 18‑21: Percutaneous VAD Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 18‑22: Percutaneous VAD Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 18‑23: Percutaneous VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 18‑24: Percutaneous VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 18‑25: Percutaneous VAD Procedures by Country, Middle East, 2020 – 2030 |
| Figure 18‑26: Percutaneous VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 18‑27: Percutaneous VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 18‑28: Percutaneous VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 18‑29: Percutaneous VAD Procedures by Country, Africa, 2020 – 2030 |
| Figure 18‑30: Implantable VAD Procedures by Region, Global, 2020 – 2030 |
| Figure 18‑31: Implantable VAD Procedures by Country, North America, 2020 – 2030 |
| Figure 18‑32: Implantable VAD Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 18‑33: Implantable VAD Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 18‑34: Implantable VAD Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 18‑35: Implantable VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 18‑36: Implantable VAD Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 18‑37: Implantable VAD Procedures by Country, Middle East, 2020 – 2030 |
| Figure 18‑38: Implantable VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 18‑39: Implantable VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 18‑40: Implantable VAD Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 18‑41: Implantable VAD Procedures by Country, Africa, 2020 – 2030 |
| Figure 18‑42: Ventricular Assist Device Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 18‑43: Ventricular Assist Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 18‑44: Ventricular Assist Device Market, Global, 2020 – 2030 |
| Figure 18‑45: Units Sold by Region, Ventricular Assist Device Market, Global, 2020 – 2030 |
| Figure 18‑46: Average Selling Price by Region, Ventricular Assist Device Market, Global, 2020 – 2030 (US$) |
| Figure 18‑47: Market Value by Region, Ventricular Assist Device Market, Global, 2020 – 2030 (US$M) |
| Figure 18‑48: Implantable VAD Market, Global, 2020 – 2030 |
| Figure 18‑49: Units Sold by Region, Implantable VAD Market, Global, 2020 – 2030 |
| Figure 18‑50: Average Selling Price by Region, Implantable VAD Market, Global, 2020 – 2030 (US$) |
| Figure 18‑51: Market Value by Region, Implantable VAD Market, Global, 2020 – 2030 (US$M) |
| Figure 18‑52: Percutaneous VAD Market, Global, 2020 – 2030 |
| Figure 18‑53: Units Sold by Region, Percutaneous VAD Market, Global, 2020 – 2030 |
| Figure 18‑54: Average Selling Price by Region, Percutaneous VAD Market, Global, 2020 – 2030 (US$) |
| Figure 18‑55: Market Value by Region, Percutaneous VAD Market, Global, 2020 – 2030 (US$M) |
| Figure 18‑56: Leading Competitors, Ventricular Assist Device Market, Global, 2023 |
| Figure 19‑1: Intra-Aortic Balloon Device Procedures Covered |
| Figure 19‑2: Ventricular Assist Device Markets Covered |
| Figure 19‑3: Intra-Aortic Balloon Device Regions Covered, Global (1 of 2) |
| Figure 19‑4: Intra-Aortic Balloon Device Regions Covered, Global (2 of 2) |
| Figure 19‑5: Intra-Aortic Balloon Pump Procedures by Region, Global, 2020 – 2030 |
| Figure 19‑6: Intra-Aortic Balloon Pump Procedures by Country, North America, 2020 – 2030 |
| Figure 19‑7: Intra-Aortic Balloon Pump Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 19‑8: Intra-Aortic Balloon Pump Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 19‑9: Intra-Aortic Balloon Pump Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 19‑10: Intra-Aortic Balloon Pump Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 19‑11: Intra-Aortic Balloon Pump Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 19‑12: Intra-Aortic Balloon Pump Procedures by Country, Middle East, 2020 – 2030 |
| Figure 19‑13: Intra-Aortic Balloon Pump Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 19‑14: Intra-Aortic Balloon Pump Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 19‑15: Intra-Aortic Balloon Pump Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 19‑16: Intra-Aortic Balloon Pump Procedures by Country, Africa, 2020 – 2030 |
| Figure 19‑17: Intra-Aortic Balloon Device Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 19‑18: Intra-Aortic Balloon Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 19‑19: IAB Catheter Market, Global, 2020 – 2030 |
| Figure 19‑20: Units Sold by Region, IAB Catheter Market, Global, 2020 – 2030 |
| Figure 19‑21: Average Selling Price by Region, IAB Catheter Market, Global, 2020 – 2030 (US$) |
| Figure 19‑22: Market Value by Region, IAB Catheter Market, Global, 2020 – 2030 (US$M) |
| Figure 19‑23: IABP Console Market, Global, 2020 – 2030 |
| Figure 19‑24: Units Sold by Region, IABP Console Market, Global, 2020 – 2030 |
| Figure 19‑25: Average Selling Price by Region, IABP Console Market, Global, 2020 – 2030 (US$) |
| Figure 19‑26: Market Value by Region, IABP Console Market, Global, 2020 – 2030 (US$M) |
| Figure 19‑27: Installed Base by Region, IABP Console Market, Global, 2020 – 2030 (US$M) |
| Figure 19‑28: Leading Competitors, Intra-Aortic Balloon Device Market, Global, 2023 |
| Figure 20‑1: Artificial Heart Replacement Procedures Covered |
| Figure 20‑2: Artificial Heart Replacement Device Regions Covered, Global (1 of 2) |
| Figure 20‑3: Artificial Heart Replacement Device Regions Covered, Global (2 of 2) |
| Figure 20‑4: Artificial Heart Replacement Procedures by Region, Global, 2020 – 2030 |
| Figure 20‑5: Artificial Heart Replacement Procedures by Country, North America, 2020 – 2030 |
| Figure 20‑6: Artificial Heart Replacement Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 20‑7: Artificial Heart Replacement Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 20‑8: Artificial Heart Replacement Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 20‑9: Artificial Heart Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 20‑10: Artificial Heart Replacement Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 20‑11: Artificial Heart Replacement Procedures by Country, Middle East, 2020 – 2030 |
| Figure 20‑12: Artificial Heart Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 20‑13: Artificial Heart Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 20‑14: Artificial Heart Replacement Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 20‑15: Artificial Heart Replacement Procedures by Country, Africa, 2020 – 2030 |
| Figure 20‑16: Artificial Heart Replacement Device Market, Global, 2020 – 2030 |
| Figure 20‑17: Units Sold by Region, Artificial Heart Replacement Device Market, Global, 2020 – 2030 |
| Figure 20‑18: Average Selling Price by Region, Artificial Heart Replacement Device Market, Global, 2020 – 2030 (US$) |
| Figure 20‑19: Market Value by Region, Artificial Heart Replacement Device Market, Global, 2020 – 2030 (US$M) |
| Figure 20‑20: Leading Competitors, Artificial Heart Replacement Device Market, Global, 2023 |
| Figure 21‑1: Patent Foramen Ovale Closure Procedures Covered |
| Figure 21‑2: Patent Foramen Ovale Closure Device Regions Covered, Global (1 of 2) |
| Figure 21‑3: Patent Foramen Ovale Closure Device Regions Covered, Global (2 of 2) |
| Figure 21‑4: Patent Foramen Ovale Closure Procedures by Region, Global, 2020 – 2030 |
| Figure 21‑5: Patent Foramen Ovale Closure Procedures by Country, North America, 2020 – 2030 |
| Figure 21‑6: Patent Foramen Ovale Closure Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 21‑7: Patent Foramen Ovale Closure Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 21‑8: Patent Foramen Ovale Closure Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 21‑9: Patent Foramen Ovale Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 21‑10: Patent Foramen Ovale Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 21‑11: Patent Foramen Ovale Closure Procedures by Country, Middle East, 2020 – 2030 |
| Figure 21‑12: Patent Foramen Ovale Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 21‑13: Patent Foramen Ovale Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 21‑14: Patent Foramen Ovale Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 21‑15: Patent Foramen Ovale Closure Procedures by Country, Africa, 2020 – 2030 |
| Figure 21‑16: Patent Foramen Ovale Closure Device Market, Global, 2020 – 2030 |
| Figure 21‑17: Units Sold by Region, Patent Foramen Ovale Closure Device Market, Global, 2020 – 2030 |
| Figure 21‑18: Average Selling Price by Region, Patent Foramen Ovale Closure Device Market, Global, 2020 – 2030 (US$) |
| Figure 21‑19: Market Value by Region, Patent Foramen Ovale Closure Device Market, Global, 2020 – 2030 (US$M) |
| Figure 21‑20: Leading Competitors, Patent Foramen Ovale Closure Device Market, Global, 2023 |
| Figure 22‑1: Patent Ductus Arteriosus Closure Procedures Covered |
| Figure 22‑2: Patent Ductus Arteriosus Closure Device Market Regions Covered, Global (1 of 2) |
| Figure 22‑3: Patent Ductus Arteriosus Closure Device Market Regions Covered, Global (2 of 2) |
| Figure 22‑4: Patent Ductus Arteriosus Closure Procedures by Region, Global, 2020 – 2030 |
| Figure 22‑5: Patent Ductus Arteriosus Closure Procedures by Country, North America, 2020 – 2030 |
| Figure 22‑6: Patent Ductus Arteriosus Closure Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 22‑7: Patent Ductus Arteriosus Closure Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 22‑8: Patent Ductus Arteriosus Closure Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 22‑9: Patent Ductus Arteriosus Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 22‑10: Patent Ductus Arteriosus Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 22‑11: Patent Ductus Arteriosus Closure Procedures by Country, Middle East, 2020 – 2030 |
| Figure 22‑12: Patent Ductus Arteriosus Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 22‑13: Patent Ductus Arteriosus Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 22‑14: Patent Ductus Arteriosus Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 22‑15: Patent Ductus Arteriosus Closure Procedures by Country, Africa, 2020 – 2030 |
| Figure 22‑16: Patent Ductus Arteriosus Closure Device Market, Global, 2020 – 2030 |
| Figure 22‑17: Units Sold by Region, Patent Ductus Arteriosus Closure Device Market, Global, 2020 – 2030 |
| Figure 22‑18: Average Selling Price by Region, Patent Ductus Arteriosus Closure Device Market, Global, 2020 – 2030 (US$) |
| Figure 22‑19: Market Value by Region, Patent Ductus Arteriosus Closure Device Market, Global, 2020 – 2030 (US$M) |
| Figure 22‑20: Leading Competitors, Patent Ductus Arteriosus Closure Device Market, Global, 2023 |
| Figure 23‑1: Atrial & Ventricular Septal Defect Closure Procedures Covered |
| Figure 23‑2: Atrial & Ventricular Septal Defect Closure Device Markets Covered |
| Figure 23‑3: Atrial & Ventricular Septal Defect Closure Device Market Regions Covered, Global (1 of 2) |
| Figure 23‑4: Atrial & Ventricular Septal Defect Closure Device Market Regions Covered, Global (2 of 2) |
| Figure 23‑5: Atrial and Ventricular Septal Defect Closure Procedures by Type, Global, 2020 – 2030 |
| Figure 23‑6: Atrial and Ventricular Septal Defect Closure Procedures by Region, Global, 2020 – 2030 |
| Figure 23‑7: Atrial and Ventricular Septal Defect Closure Procedures by Country, North America, 2020 – 2030 |
| Figure 23‑8: Atrial and Ventricular Septal Defect Closure Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 23‑9: Atrial and Ventricular Septal Defect Closure Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 23‑10: Atrial and Ventricular Septal Defect Closure Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 23‑11: Atrial and Ventricular Septal Defect Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 23‑12: Atrial and Ventricular Septal Defect Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 23‑13: Atrial and Ventricular Septal Defect Closure Procedures by Country, Middle East, 2020 – 2030 |
| Figure 23‑14: Atrial and Ventricular Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 23‑15: Atrial and Ventricular Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 23‑16: Atrial and Ventricular Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 23‑17: Atrial and Ventricular Septal Defect Closure Procedures by Country, Africa, 2020 – 2030 |
| Figure 23‑18: Atrial Septal Defect Closure Procedures by Region, Global, 2020 – 2030 |
| Figure 23‑19: Atrial Septal Defect Closure Procedures by Country, North America, 2020 – 2030 |
| Figure 23‑20: Atrial Septal Defect Closure Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 23‑21: Atrial Septal Defect Closure Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 23‑22: Atrial Septal Defect Closure Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 23‑23: Atrial Septal Defect Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 23‑24: Atrial Septal Defect Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 23‑25: Atrial Septal Defect Closure Procedures by Country, Middle East, 2020 – 2030 |
| Figure 23‑26: Atrial Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 23‑27: Atrial Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 23‑28: Atrial Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 23‑29: Atrial Septal Defect Closure Procedures by Country, Africa, 2020 – 2030 |
| Figure 23‑30: Ventricular Septal Defect Closure Procedures by Region, Global, 2020 – 2030 |
| Figure 23‑31: Ventricular Septal Defect Closure Procedures by Country, North America, 2020 – 2030 |
| Figure 23‑32: Ventricular Septal Defect Closure Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 23‑33: Ventricular Septal Defect Closure Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 23‑34: Ventricular Septal Defect Closure Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 23‑35: Ventricular Septal Defect Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 23‑36: Ventricular Septal Defect Closure Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 23‑37: Ventricular Septal Defect Closure Procedures by Country, Middle East, 2020 – 2030 |
| Figure 23‑38: Ventricular Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 23‑39: Ventricular Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 23‑40: Ventricular Septal Defect Closure Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 23‑41: Ventricular Septal Defect Closure Procedures by Country, Africa, 2020 – 2030 |
| Figure 23‑42: Atrial & Ventricular Septal Defect Closure Device Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 23‑43: Atrial & Ventricular Septal Defect Closure Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 23‑44: Atrial & Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 |
| Figure 23‑45: Units Sold by Region, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 |
| Figure 23‑46: Average Selling Price by Region, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 (US$) |
| Figure 23‑47: Market Value by Region Atrial & Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 (US$M) |
| Figure 23‑48: Atrial Septal Defect Closure Device Market, Global, 2020 – 2030 |
| Figure 23‑49: Units Sold by Region, Atrial Septal Defect Closure Device Market, Global, 2020 – 2030 |
| Figure 23‑50: Average Selling Price by Region, Atrial Septal Defect Closure Device Market, Global, 2020 – 2030 (US$) |
| Figure 23‑51: Market Value by Region, Atrial Septal Defect Closure Device Market, Global, 2020 – 2030 (US$M) |
| Figure 23‑52: Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 |
| Figure 23‑53: Units Sold by Region, Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 |
| Figure 23‑54: Average Selling Price by Region, Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 (US$) |
| Figure 23‑55: Market Value by Region, Ventricular Septal Defect Closure Device Market, Global, 2020 – 2030 (US$M) |
| Figure 23‑56: Leading Competitors, Atrial & Ventricular Septal Defect Closure Device Market, Global, 2023 |
| Figure 24‑1: Left Atrial Appendage Closure Device Procedures Covered |
| Figure 24‑2: Left Atrial Appendage Closure Device Markets Covered |
| Figure 24‑3: Left Atrial Appendage Closure Device Regions Covered, Global (1 of 2) |
| Figure 24‑4: Left Atrial Appendage Closure Device Regions Covered, Global (2 of 2) |
| Figure 24‑5: Left Atrial Appendage Closure Device Procedures by Type, Global, 2020 – 2030 |
| Figure 24‑6: Left Atrial Appendage Closure Device Procedures by Region, Global, 2020 – 2030 |
| Figure 24‑7: Left Atrial Appendage Closure Device Procedures by Country, North America, 2020 – 2030 |
| Figure 24‑8: Left Atrial Appendage Closure Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 24‑9: Left Atrial Appendage Closure Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 24‑10: Left Atrial Appendage Closure Device Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 24‑11: Left Atrial Appendage Closure Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 24‑12: Left Atrial Appendage Closure Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 24‑13: Left Atrial Appendage Closure Device Procedures by Country, Middle East, 2020 – 2030 |
| Figure 24‑14: Left Atrial Appendage Closure Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 24‑15: Left Atrial Appendage Closure Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 24‑16: Left Atrial Appendage Closure Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 24‑17: Left Atrial Appendage Closure Device Procedures by Country, Africa, 2020 – 2030 |
| Figure 24‑18: Endocardial Device Procedures by Region, Global, 2020 – 2030 |
| Figure 24‑19: Endocardial Device Procedures by Country, North America, 2020 – 2030 |
| Figure 24‑20: Endocardial Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 24‑21: Endocardial Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 24‑22: Endocardial Device Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 24‑23: Endocardial Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 24‑24: Endocardial Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 24‑25: Endocardial Device Procedures by Country, Middle East, 2020 – 2030 |
| Figure 24‑26: Endocardial Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 24‑27: Endocardial Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 24‑28: Endocardial Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 24‑29: Endocardial Device Procedures by Country, Africa, 2020 – 2030 |
| Figure 24‑30: Epicardial Device Procedures by Region, Global, 2020 – 2030 |
| Figure 24‑31: Epicardial Device Procedures by Country, North America, 2020 – 2030 |
| Figure 24‑32: Epicardial Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 24‑33: Epicardial Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 24‑34: Epicardial Device Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 24‑35: Epicardial Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 24‑36: Epicardial Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 24‑37: Epicardial Device Procedures by Country, Middle East, 2020 – 2030 |
| Figure 24‑38: Epicardial Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 24‑39: Epicardial Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 24‑40: Epicardial Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 24‑41: Epicardial Device Procedures by Country, Africa, 2020 – 2030 |
| Figure 24‑42: Left Atrial Appendage Closure Device Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 24‑43: Left Atrial Appendage Closure Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 24‑44: Left Atrial Appendage Closure Device Market, Global, 2020 – 2030 |
| Figure 24‑45: Units Sold by Region, Left Atrial Appendage Closure Device Market, Global, 2020 – 2030 |
| Figure 24‑46: Average Selling Price by Region, Left Atrial Appendage Closure Device Market, Global, 2020 – 2030 (US$) |
| Figure 24‑47: Market Value by Region, Left Atrial Appendage Closure Device Market, Global, 2020 – 2030 (US$M) |
| Figure 24‑48: Endocardial LAA Device Market, Global, 2020 – 2030 |
| Figure 24‑49: Units Sold by Region, Endocardial LAA Device Market, Global, 2020 – 2030 |
| Figure 24‑50: Average Selling Price by Region, Endocardial LAA Device Market, Global, 2020 – 2030 (US$) |
| Figure 24‑51: Market Value by Region, Endocardial LAA Device Market, Global, 2020 – 2030 (US$M) |
| Figure 24‑52: Epicardial Clip LAA Device Market, Global, 2020 – 2030 |
| Figure 24‑53: Units Sold by Region, Epicardial Clip LAA Device Market, Global, 2020 – 2030 |
| Figure 24‑54: Average Selling Price by Region, Epicardial Clip LAA Device Market, Global, 2020 – 2030 (US$) |
| Figure 24‑55: Market Value by Region, Epicardial Clip LAA Device Market, Global, 2020 – 2030 (US$M) |
| Figure 24‑56: Epicardial Suture LAA Device Market, Global, 2020 – 2030 |
| Figure 24‑57: Units Sold by Region, Epicardial Suture LAA Device Market, Global, 2020 – 2030 |
| Figure 24‑58: Average Selling Price by Region, Epicardial Clip Suture Device Market, Global, 2020 – 2030 (US$) |
| Figure 24‑59: Market Value by Region, Epicardial Clip Suture Device Market, Global, 2020 – 2030 (US$M) |
| Figure 24‑60: Leading Competitors, Left Atrial Appendage Closure Device Market, Global, 2023 |
| Figure 25‑1: Preshaped Guidewire Procedures Covered |
| Figure 25‑2: Preshaped Guidewire Market Regions Covered, Global (1 of 2) |
| Figure 25‑3: Preshaped Guidewire Market Regions Covered, Global (2 of 2) |
| Figure 25‑4: TAVR Procedures by Region, Global, 2020 – 2030 |
| Figure 25‑5: TAVR Procedures by Country, North America, 2020 – 2030 |
| Figure 25‑6: TAVR Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 25‑7: TAVR Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 25‑8: TAVR Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 25‑9: TAVR Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 25‑10: TAVR Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 25‑11: TAVR Procedures by Country, Middle East, 2020 – 2030 |
| Figure 25‑12: TAVR Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 25‑13: TAVR Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 25‑14: TAVR Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 25‑15: TAVR Procedures by Country, Africa, 2020 – 2030 |
| Figure 25‑16: Preshaped Guidewire Market, Global, 2020 – 2030 |
| Figure 25‑17: Units Sold by Region, Preshaped Guidewire Market, Global, 2020 – 2030 |
| Figure 25‑18: Average Selling Price by Region, Preshaped Guidewire Market, Global, 2020 – 2030 (US$) |
| Figure 25‑19: Market Value by Region, Preshaped Guidewire Market, Global, 2020 – 2030 (US$M) |
| Figure 25‑20: Leading Competitors, Preshaped Guidewire Market, Global, 2023 |
| Figure 26‑1: Transmyocardial Revascularization Device Procedures Covered |
| Figure 26‑2: Transymyocardial Revascularization Device Markets Covered |
| Figure 26‑3: Transmyocardial Revascularization Device Regions Covered, Global (1 of 2) |
| Figure 26‑4: Transmyocardial Revascularization Device Regions Covered, Global (2 of 2) |
| Figure 26‑5: Transmyocardial Revascularization Device Procedures by Region, Global, 2020 – 2030 |
| Figure 26‑6: Transmyocardial Revascularization Device Procedures by Country, North America, 2020 – 2030 |
| Figure 26‑7: Transmyocardial Revascularization Device Procedures by Country, Latin America, 2020 – 2030 (1 of 2) |
| Figure 26‑8: Transmyocardial Revascularization Device Procedures by Country, Latin America, 2020 – 2030 (2 of 2) |
| Figure 26‑9: Transmyocardial Revascularization Device Procedures by Country, Western Europe, 2020 – 2030 |
| Figure 26‑10: Transmyocardial Revascularization Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (1 of 2) |
| Figure 26‑11: Transmyocardial Revascularization Device Procedures by Country, Central & Eastern Europe, 2020 – 2030 (2 of 2) |
| Figure 26‑12: Transmyocardial Revascularization Device Procedures by Country, Middle East, 2020 – 2030 |
| Figure 26‑13: Transmyocardial Revascularization Device Procedures by Country, Asia-Pacific, 2020 – 2030 (1 of 3) |
| Figure 26‑14: Transmyocardial Revascularization Device Procedures by Country, Asia-Pacific, 2020 – 2030 (2 of 3) |
| Figure 26‑15: Transmyocardial Revascularization Device Procedures by Country, Asia-Pacific, 2020 – 2030 (3 of 3) |
| Figure 26‑16: Transmyocardial Revascularization Device Procedures by Country, Africa, 2020 – 2030 |
| Figure 26‑17: Transmyocardial Revascularization Device Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 26‑18: Transmyocardial Revascularization Device Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 26‑19: Single-Use Fiber-Optic Handpiece Market, Global, 2020 – 2030 |
| Figure 26‑20: Units Sold by Region, Single-Use Fiber-Optic Handpiece Market, Global, 2020 – 2030 |
| Figure 26‑21: Average Selling Price by Region, Single-Use Fiber-Optic Handpiece Market, Global, 2020 – 2030 (US$) |
| Figure 26‑22: Market Value by Region, Single-Use Fiber-Optic Handpiece Market, Global, 2020 – 2030 (US$M) |
| Figure 26‑23: Laser Console Market, Global, 2020 – 2030 |
| Figure 26‑24: Market Value by Region, Laser Console Market, Global, 2020 – 2030 (US$M) |
| Figure 26‑25: Leading Competitors, Transmyocardial Revascularization Device Market, Global, 2023 |
| Figure 27‑1: Extracorporeal Membrane Oxygenation Procedures Covered |
| Figure 27‑2: Extracorporeal Membrane Oxygenation Markets Covered |
| Figure 27‑3: Extracorporeal Membrane Oxygenation Market Regions Covered, Global (1 of 2) |
| Figure 27‑4: Extracorporeal Membrane Oxygenation Market Regions Covered, Global (2 of 2) |
| Figure 27‑5: Extracorporeal Membrane Oxygenation Procedures by Region, Global, 2020 – 2030 |
| Figure 27‑6: Extracorporeal Membrane Oxygenation Procedures by Modality, Global, 2020 – 2030 |
| Figure 27‑7: Venoarterial ECMO Procedures by Region, Global, 2020 – 2030 |
| Figure 27‑8: Venovenous ECMO Procedures by Region, Global, 2020 – 2030 |
| Figure 27‑9: Arteriovenous ECMO Procedures by Region, Global, 2020 – 2030 |
| Figure 27‑10: Extracorporeal Membrane Oxygenation Procedures by Modality, Global, 2020 – 2030 |
| Figure 27‑11: Respiratory ECMO Procedures by Region, Global, 2020 – 2030 |
| Figure 27‑12: Cardiac ECMO Procedures by Region, Global, 2020 – 2030 |
| Figure 27‑13: eCPR ECMO Procedures by Region, Global, 2020 – 2030 |
| Figure 27‑14: Extracorporeal Membrane Oxygenation Market by Segment, Global, 2020 – 2030 (US$M) |
| Figure 27‑15: Extracorporeal Membrane Oxygenation Market by Region, Global, 2020 – 2030 (US$M) |
| Figure 27‑16: ECMO Disposables Market, Global, 2020 – 2030 |
| Figure 27‑17: Units Sold by Region, ECMO Disposables Market, Global, 2020 – 2030 |
| Figure 27‑18: Average Selling Price by Region, ECMO Disposables Market, Global, 2020 – 2030 (US$) |
| Figure 27‑19: Market Value by Region, ECMO Disposables Market, Global, 2020 – 2030 (US$M) |
| Figure 27‑20: ECMO Machine Market, Global, 2020 – 2030 |
| Figure 27‑21: Units Sold by Region, ECMO Machine Market, Global, 2020 – 2030 |
| Figure 27‑22: Average Selling Price by Region, ECMO Machine Market, Global, 2020 – 2030 (US$) |
| Figure 27‑23: Market Value by Region, ECMO Machine Market, Global, 2020 – 2030 (US$M) |
| Figure 27‑24: Leading Competitors, Extracorporeal Membrane Oxygenation Market, Global, 2023 |
